18444-66-1
基本信息
葫蘆素 E
葫蘆素E對(duì)照品
葫蘆素E(標(biāo)準(zhǔn)品)
葫蘆素E(葫蘆苦素E)
葫蘆素 E, >99%
葫蘆素 E, 來源于甜瓜
A-ELATERIN
Cucurbit E
α-Elaterine
CUCURBITACIN E
ALPHA-ELATERIN
cucurbitacine-e
alpha-elaterine
CUCURBITACIN E(SH)
CUCURBITACIN E hplc
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
應(yīng)用領(lǐng)域
藥理藥效:用于治療慢性肝炎。1細(xì)胞毒與抗癌作用,2抗肝損害,3提高機(jī)體免疫功能。
常見問題列表
cyclin B1/CDC2
|
Autophagy
|
To explore the antitumor activity of Cucurbitacin E (CuE) against colorectal cancer (CRC) cells, an in vitro study is initiated in which each of the CRC cell lines is exposed to increasing doses of Cucurbitacin E (0, 2.5, 5, and 7.5?μM) over a period of 24?h. The proliferation of the Cucurbitacin E-treated cancer cells is then measured using the MTT method. Cucurbitacin E is shown to induce morphological changes in the primary colon cancer cells. Microscopic observation showed that following exposure to Cucurbitacin E (5?μM) between 6 and 24?h, the primary colon cancer cells underwent a remarkable change in morphology. Cucurbitacin E inhibits tumor growth by arresting the cell cycle in the G 2 /M phase via GADD45γ gene expression and the blockage of cyclin B1/CDC2 complex in primary CRC cells.
A high fat diet mice model of metabolic syndrome (HFD-MetS) is developed to assess the role of Cucurbitacin E (CuE) on body weight and fat tissue biology. Significant decrease in body weights of HFD-MetS mice treated with Cucurbitacin E (0.5mg/kg) are found as compared to HFD-MetS mice treated with vehicle alone. Cucurbitacin E treatment reduces all fat pads weights in HFD-MetS mice. 55% reduction is observed in total fat in mice, after treatment with Cucurbitacin E in comparison to HFD-MetS mice. Abdominal obesity is strongly associated with metabolic syndrome. Central obesity is reduced to 50% after Cucurbitacin E treatment as compared to HFD MetS mice, elucidating the effectiveness of Cucurbitacin E in targeting MetS.